The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PFS to predict long-term OS after first-line treatment for advanced renal cell carcinoma (aRCC): Correlation and power analysis of randomized trials (RCT).
Michele Milella
No relevant relationships to disclose
Francesco Massari
No relevant relationships to disclose
Francesca La Russa
No relevant relationships to disclose
Francesca Maines
No relevant relationships to disclose
Alessandra Felici
No relevant relationships to disclose
Vanja Vaccaro
No relevant relationships to disclose
Camillo Porta
No relevant relationships to disclose
Sergio Bracarda
No relevant relationships to disclose
Francesco Cognetti
No relevant relationships to disclose
Diana Giannarelli
No relevant relationships to disclose
Giampaolo Tortora
No relevant relationships to disclose
Emilio Bria
No relevant relationships to disclose